Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

enVVeno Medical Corp (NVNO)

  • Business News
  • Jan. 15, 2026, 13:03 UTC
  • 6
  • 1 comments

enVVeno Medical Announces Reverse Stock Split

Market reaction Comment Full text

Cognex Corporation (CGNX)

  • Business News
  • Jan. 15, 2026, 13:00 UTC
  • 8
  • 1 comments

Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates

Market reaction Comment Full text

Curaleaf Hldgs Inc. (CURLF)

  • Business News
  • Jan. 15, 2026, 12:45 UTC
  • 5
  • 1 comments

Curaleaf Celebrates Opening of Lauderhill, Florida Dispensary

Market reaction Comment Full text

Zimmer Biomet Holdings Inc (ZBH)

  • Business News
  • Jan. 15, 2026, 12:32 UTC
  • 5
  • 1 comments

Zimmer Biomet Holdings, Inc. Notification

Market reaction Comment Full text

Profound Medical Corp (PROF)

  • Business News
  • Jan. 15, 2026, 12:30 UTC
  • 5
  • 1 comments

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

Market reaction Comment Full text

Medicenna Therapeutics Corp (MDNAF)

  • Business News
  • Jan. 15, 2026, 12:30 UTC
  • 5
  • 1 comments

Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook

Market reaction Comment Full text

Zimmer Biomet Holdings Inc (ZBH)

  • Business News
  • Jan. 15, 2026, 12:30 UTC
  • 5
  • 1 comments

Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results

Market reaction Comment Full text

Agenus Inc. (AGEN)

  • Business News
  • Jan. 15, 2026, 12:01 UTC
  • 4
  • 1 comments

Agenus Inc. - Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

Market reaction Comment Full text

Agenus Inc. (AGEN)

  • Business News
  • Jan. 15, 2026, 12:01 UTC
  • 5
  • 1 comments

Agenus Announces Closing of $141M Strategic Collaboration with Zydus Lifesciences to Advance BOT+BAL and Strengthen U.S. Manufacturing Readiness

Market reaction Comment Full text

Penumbra Inc (PEN)

  • Business News
  • Jan. 15, 2026, 12:00 UTC
  • 4
  • 1 comments

Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results

Market reaction Comment Full text
  • Previous
  • 53
  • 54
  • 55
  • 56
  • 57
  • Next

Search

News categories

  • Technical Exchange News(10847)
  • Event(2223)
  • SEC News(187893)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124366)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin